UBS Group’s Barington/Hilco Acquisition Corp. Rights BHACR Stock Holding History

UBS Group’s Portfolio BHACR Stock Details BHACR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-234	Closed	–	–	8652
2018 Q3	$0	Hold	234	–	–	﹤0.01%	8524
2018 Q2	$0	Sell	234 -1,800	-88%	-$412	﹤0.01%	8493
2018 Q1	$1K	Buy	2,034 +20	+1%	+$6	﹤0.01%	7728
2017 Q4	$0	Buy	2,014 +800	+66%	+$161	﹤0.01%	8310
2017 Q3	$0	Hold	1,214	–	–	﹤0.01%	8222
2017 Q2	$0	Buy	+1,214	New	+$451	﹤0.01%	8238
2016 Q4	–	Sell	-1,400	Closed	–	–	8254
2016 Q3	$0	Buy	+1,400	New	+$278	﹤0.01%	8145

UBS Group's BHACR Position: Q4 2018 in Review

UBS Group sold out of Barington/Hilco Acquisition Corp. Rights (BHACR) in Q4 2018, closing a stake of 234 shares.

UBS Group first reported a position in BHACR in Q3 2016 and held it in 7 quarters. The position peaked at $1K in Q1 2018. 0 funds tracked by Wall St. Rank hold BHACR as of Q4 2018.

UBS Group reported no remaining Barington/Hilco Acquisition Corp. Rights position as of Q4 2018 after selling out during the quarter.
UBS Group sold 234 Barington/Hilco Acquisition Corp. Rights shares in Q4 2018.
UBS Group first reported a position in Barington/Hilco Acquisition Corp. Rights in Q3 2016 and held it in 7 quarters.
UBS Group's Barington/Hilco Acquisition Corp. Rights position peaked at $1K in Q1 2018.
0 funds tracked by Wall St. Rank held Barington/Hilco Acquisition Corp. Rights as of Q4 2018.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.